We are live on
!
Find out more
RL
Ruffer LLP Portfolio holdings
AUM
$2.44B
1-Year Est. Return
44.75%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+44.75%
3 Year Est. Return
+105.9%
5 Year Est. Return
+158.64%
10 Year Est. Return
+642.68%
AUM
$3.27B
AUM Growth
+$320M
(+11%)
Cap. Flow
+$146M
Cap. Flow
% of AUM
4.48%
Top 10 Holdings %
Top 10 Hldgs %
67.68%
Holding
89
New
8
Increased
19
Reduced
31
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$147M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$145M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$102M |
| 4 |
Cigna
CI
|
+$82.3M |
| 5 |
Ambev
ABEV
|
+$79.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$191M |
| 2 |
General Motors
GM
|
+$59.5M |
| 3 |
Cemex
CX
|
+$54.3M |
| 4 |
Strategy Inc
MSTR
|
+$53.6M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$50.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.75% |
| 2 | Financials | 22.96% |
| 3 | Materials | 22.22% |
| 4 | Consumer Staples | 9.31% |
| 5 | Energy | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Centene
CNC
$31.3B
| $354M | 10.83% |
5,536,706
+2,373,204
| +75% | +$147M |
|
|
2
Cigna
CI
$76.6B
| $326M | 9.98% |
1,348,700
+369,217
| +38% | +$82.3M |
|
|
3
Ambev
ABEV
$47.3B
| $269M | 8.22% |
97,480,397
+28,205,861
| +41% | +$79.6M |
|
|
4
Bristol-Myers Squibb
BMY
$127B
| $265M | 8.11% |
4,196,856
+2,327,044
| +124% | +$145M |
|
5
Kinross Gold
KGC
$28.5B
| $224M | 6.85% |
33,532,930
+6,942,948
| +26% | +$48.3M |
|
6
American Express
AXP
$223B
| $220M | 6.72% |
1,551,574
-285,655
| -16% | -$37.7M |
|
|
SCHW
7
Charles Schwab
SCHW
$177B
| $182M | 5.56% |
2,786,032
-830,070
| -23% | -$50.3M |
|
8
Wheaton Precious Metals
WPM
$50.6B
| $137M | 4.2% |
3,590,891
+816,986
| +29% | +$32.4M |
|
9
eHealth
EHTH
$42.5M
| $133M | 4.07% |
1,830,110
+382,381
| +26% | +$24.4M |
|
|
10
General Motors
GM
$74.7B
| $103M | 3.16% |
1,799,132
-1,120,742
| -38% | -$59.5M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
| $100M | 3.07% |
+656,688
| New | +$102M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.07T
| $99.5M | 3.04% |
389,041
-138,784
| -26% | -$33.7M |
|
|
CTRA
13
DELISTED
Coterra Energy
CTRA
| $76.3M | 2.33% |
4,062,794
+1,289,128
| +46% | +$23.7M |
|
14
AngloGold Ashanti
AU
$40.3B
| $67.1M | 2.05% |
3,052,826
-565,697
| -16% | -$12.7M |
|
|
15
Walt Disney
DIS
$165B
| $61.4M | 1.88% |
332,681
-1,037,565
| -76% | -$191M |
|
16
Nutrien
NTR
$32.7B
| $57.3M | 1.75% |
1,063,520
+7,820
| +0.7% | +$425K |
|
17
Aflac
AFL
$63.9B
| $52.4M | 1.6% |
1,022,473
-221,879
| -18% | -$10.6M |
|
18
Newmont
NEM
$98.2B
| $52.2M | 1.6% |
865,474
+742,986
| +607% | +$44.5M |
|
19
JPMorgan Chase
JPM
$939B
| $47.9M | 1.47% |
314,664
-55,956
| -15% | -$8.05M |
|
20
Gold Fields
GFI
$29.2B
| $45.9M | 1.4% |
4,833,096
-2,596,764
| -35% | -$24.2M |
|
21
ExxonMobil
XOM
$651B
| $38.1M | 1.17% |
682,944
+515,755
| +308% | +$27M |
|
|
EXE
22
Expand Energy Corp
EXE
$21.9B
| $37.8M | 1.16% |
+870,000
| New | +$38.3M |
|
23
IAMGOLD
IAG
$8.47B
| $33.4M | 1.02% |
11,225,371
-7,978,529
| -42% | -$26.4M |
|
24
Check Point Software Technologies
CHKP
$13.3B
| $29.8M | 0.91% |
266,512
-162,569
| -38% | -$19.6M |
|
|
GAU
25
Galiano Gold
GAU
$486M
| $29.7M | 0.91% |
26,822,077
-192,339
| -0.7% | -$229K |
|
Similar funds
QT
TMC
GWM
KFA
BW
M
BBA
PUI
Ruffer LLP's Q1 2021 Portfolio in Review
As of Q1 2021, Ruffer LLP held 89 positions worth $3.27B, up 11% from $2.95B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Ruffer LLP deployed $146M of net new capital in Q1 2021, opening 8 new positions and adding to 19 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 656,688 shares worth $100M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 18% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Walt Disney, an estimated $191M trimmed.
- Ruffer LLP's largest Q1 2021 buy was Alexion Pharmaceuticals: 656,688 shares worth $100M.
- Ruffer LLP added most to Centene in Q1 2021, an estimated $147M increase.
- Ruffer LLP's biggest Q1 2021 reduction was Walt Disney, cutting an estimated $191M.
- Ruffer LLP fully exited Strategy Inc in Q1 2021, selling an estimated $53.6M.
- Ruffer LLP's ten largest holdings make up 68% of its $3.27B portfolio in Q1 2021.
- Ruffer LLP opened 8 new positions and closed 13 in Q1 2021.
- Ruffer LLP's portfolio value rose 11% quarter-over-quarter to $3.27B.
Based on Ruffer LLP's 13F filing for Q1 2021, filed 11 May 2021.